$709 Million is the total value of Fairmount Funds Management LLC's 17 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $121,639,028 | +61.6% | 2,884,492 | 0.0% | 17.15% | +32.5% | ||
| VRDN | VIRIDIAN THERAPEUTICS INC | $32,583,331 | -6.5% | 1,369,623 | 0.0% | 4.59% | -23.3% | |
| ARGX | ARGENX SEsponsored adr | $28,655,288 | +4.6% | 73,526 | 0.0% | 4.04% | -14.2% | |
| TYRA BIOSCIENCES INC | $24,131,476 | +6.0% | 1,416,998 | 0.0% | 3.40% | -13.1% | ||
| TERN | TERNS PHARMACEUTICALS INC | $17,850,000 | -26.1% | 2,040,000 | 0.0% | 2.52% | -39.4% | |
| ASTRIA THERAPEUTICS INC | $15,838,637 | -37.4% | 1,901,397 | 0.0% | 2.23% | -48.7% | ||
| DBVT | DBV TECHNOLOGIES SAsponsored adr | $13,423,432 | +12.4% | 7,064,964 | 0.0% | 1.89% | -7.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ARGENX SE | 16 | Q3 2023 | 9.3% |
| AXSOME THERAPEUTICS INC | 15 | Q3 2023 | 24.6% |
| INSMED INC | 12 | Q3 2022 | 15.0% |
| ACADIA PHARMACEUTICALS INC | 12 | Q3 2022 | 15.5% |
| IOVANCE BIOTHERAPEUTICS INC | 12 | Q3 2022 | 9.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 7.2% |
| ENANTA PHARMACEUTICALS INC | 12 | Q3 2022 | 9.6% |
| ALLAKOS INC | 12 | Q3 2022 | 7.4% |
| AMARIN CORP PLC | 12 | Q3 2022 | 10.9% |
| VERONA PHARMA PLC | 12 | Q2 2023 | 11.9% |
View Fairmount Funds Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | June 30, 2023 | 17,230,540 | 20.0% |
| Olema Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CATABASIS PHARMACEUTICALS INC | June 17, 2021 | 4,092,166 | 5.3% |
| MIRAGEN THERAPEUTICS, INC. | January 05, 2021 | 967,671 | 20.0% |
| Unum Therapeutics Inc. | July 10, 2020 | 7,482,460 | 20.0% |
View Fairmount Funds Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-05-28 |
| 4 | 2024-05-16 |
| 13F-HR | 2024-05-15 |
| 4 | 2024-04-25 |
| SC 13D/A | 2024-04-25 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| SC 13D/A | 2024-04-01 |
View Fairmount Funds Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.